Therapeutic Expertise
30+ Product Approvals Supported Across 500+ Studies, Let Our Expertise Help Guide Your Development Strategy
With extensive experience in key therapeutic areas such as oncology, neurology, and ophthalmology SDC aligns its teams therapeutically to ensure we bring this knowledge to the front line of our services.
Since our inception in 2005 SDC has worked across a broad therapeutic spectrum. With extensive experience in oncology, neurology, and ophthalmology SDC aligns its teams therapeutically to ensure we bring this knowledge to the front line of our services. With a deep bench of therapeutic knowledge and a long history of supporting clients at the FDA and other regulatory agencies, SDC works to support data-enabled development of a regulatory strategy that will offer the best opportunity for success.
Ophthalmology
20+ Product Approvals and Counting
Oncology
Supporting the Next Generation of Cancer Therapy Through Thoughtful Guidance
Neurology / CNS
Thoughtful Collaboration with Your Team to Guide Your Development Strategy
Other Therapeutic Areas
Supporting Your Growth and Expansion Needs into All Therapeutic Areas
Therapeutic Area Experience
Ophthalmology
20+ Product Approvals and Counting
Ophthalmology Experience:
Extensive Ophthalmology experience across the SDC project Teams
All phases of ophthalmic drug development:
20+ Ophthalmology Product Approvals
Frequent interaction with regulatory agencies
Supported development of CDISC standards for ophthalmology
Ophthalmic Indications
Achromatopsia
AMD: Wet & Dry
Atopic Keratoconjunctivitis
Bacterial Corneal Ulcers
Blepharitis
Conjunctivitis: Allergic, Bacterial, Viral
Contact Lens
Contact Lens Solution
Corneal Deposit
Corneal Incision Sealant
Diabetic Macular Edema (DME)
Diabetic Retinopathy
Dry Eye
Glaucoma: Drug, Device
Impaired Dark Adaptation
Inflammation: Anterior/Posterior Chamber, Post-Operative
Inherited Retinal Disease
Intraocular Lens: Aspheric, Refractive
Leber’s Congenital Amaurosis (LCA)
Lid Scrub
Meibomian Gland Dysfunction
Microkeratome
Neurotrophic Keratopathy
Ocular & Systemic Safety
Ocular Redness
Optical Coherence Tomography Device
Phacoemulsification
Pediatric Cataract
Presbyopia
Retinal Disease
Retinitis Pigmentosa
Retinoschisis
Specular Microscope
Spheric IOL
Tonometer
Uveitis: Anterior, Posterior
Vitreal Detachment
X-linked Retinoschisis (XLRS)
Oncology
Supporting the Next Generation of Cancer Therapy Through Thoughtful Guidance
SDC’s dynamic oncology expertise spans various tumor types and oncology indications.
Oncology Expertise:
Supported over 60+ Oncology studies in last 5 years
All Phases and Study Designs:
Adaptive design, Bayesian analysis, Early phase through global Phase 3 drug studies
Frequent interaction with global regulatory agencies
10+ regulatory submissions supported
Rare disease and pediatric oncology expertise
Oncology Indications
Acute Myeloid Leukemia (AML)
Advanced Solid Tumors
B-Cell Lymphoma
Bladder Cancer
Bone Marrow Cancers
Breast Cancers
CHK1 Inhibitors
Chronic Lymphocytic Lymphoma (CLL)
Colorectal Cancer
Endometrial Carcinoma
Gastrointestinal Cancer
Head and Neck Cancer
Hematologic Malignancies
Hepatocellular Cancer
Hodgkin’s Lymphoma
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lung Neuroendocrine Tumors (NET)
Melanoma
Metastatic Breast Cancer
Metastatic Solid Tumors
Multiple Myeloma
Myelodysplastic Syndrome (MDS)
Myelofibrosis
Non-Hodgkin’s Lymphoma
Non-Small Cell Lung Cancer (NSCLC)
Ovarian Cancer
Pancreatic Cancer
Perivascular Epithelioid Cell Neoplasm (PEComa)
Prostate Cancer
Recurrent Glioblastoma Multiforme (GBM)
Renal Cancer
Skin Cancer
Small Cell Lung Cancer
Soft Tissue Carcinomas
Solid Tumors
Spinal Tumors
Thymus Neuroendocrine Tumors
Uveal Melanoma
Neurology / CNS
Thoughtful Collaboration with Your Team to Guide Your Development Strategy
SDC has extensive experience across multiple neurology indications from early phase through pivotal submission studies. With an end-to-end technology suite of solutions and a dedicated experienced team in neurological studies, SDC- Empowering Clinical Decisions.
Neurology Expertise:
Actively supporting multiple pharmaceutical and medical device/ diagnostic programs in CNS
All Phases and Study Designs including multiple ascending dose, PK, and pivotal submission trials
Full Service Clinical Trial Management with extensive neurology experience
Neurology Indications
Acute Spinal Cord Injury
ADHD: Adult, Adolescent
Alzheimer’s Disease
Amyotrophic Lateral Sclerosis (ALS)
Aneurysm
Autism
Cervical Spondylotic Myelopathy
Chronic Low Back Pain
Diabetic Neuropathy
Dystonia
Fibromyalgia
Major Depressive Disorder: Adult, Pediatric
Migraine Headache
Multiple Sclerosis (MS)
Muscular Dystrophy
Neurodegenerative Diseases
Pain Management
Postherpetic Neuralgia
Schizophrenia
Sleep Disorder
Traumatic Brain Injury (TBI)
Other Therapeutic Areas
Supporting Your Growth and Expansion Needs into All Therapeutic Areas
Having supported over 500+ studies since inception, SDC provides you an experienced team and an end-to-end technology suite to support multiple therapeutic areas. Our expertise spans from first-in-human to Phase 4, including supporting 30+ product approvals.